bisoprolol has been researched along with Postoperative Complications in 30 studies
Bisoprolol: A cardioselective beta-1 adrenergic blocker. It is effective in the management of HYPERTENSION and ANGINA PECTORIS.
Postoperative Complications: Pathologic processes that affect patients after a surgical procedure. They may or may not be related to the disease for which the surgery was done, and they may or may not be direct results of the surgery.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Bisoprolol reduces the perioperative incidence of death from cardiac causes and nonfatal myocardial infarction in high-risk patients who are undergoing major vascular surgery." | 9.09 | The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group. ( Baars, HF; Bax, JJ; Blankensteijn, JD; Boersma, E; Poldermans, D; Roelandt, JR; Thomson, IR; Trocino, G; van de Ven, LL; van Urk, H; Vigna, C; Yo, TI, 1999) |
| "Bisoprolol significantly reduced long-term cardiac death and myocardial infarction in high-risk patients after successful major cardiac vascular surgery." | 9.09 | Bisoprolol reduces cardiac death and myocardial infarction in high-risk patients as long as 2 years after successful major vascular surgery. ( Baars, HF; Bax, JJ; Boersma, E; Paelinck, B; Poldermans, D; Roelandt, JR; Scheffer, MG; Thomson, IR; Trocino, G; van de Ven, LL; van Urk, H; Vigna, C, 2001) |
| "Bisoprolol was associated with a significant reduction of 30-day cardiac death and nonfatal MI, while fluvastatin showed a trend for improved outcome." | 7.84 | Bisoprolol and fluvastatin for the reduction of perioperative cardiac mortality and myocardial infarction in intermediate-risk patients undergoing noncardiovascular surgery: a randomized controlled trial (DECREASE-IV). ( Bax, JJ; Boersma, E; Dunkelgrun, M; Koopman-van Gemert, AW; Poldermans, D; Schouten, O; Thomson, IR; van Poorten, F, 2009) |
| "The use of metoprolol and atenolol is associated with increased risks of postoperative stroke, compared with bisoprolol." | 7.79 | Selective β1-antagonism with bisoprolol is associated with fewer postoperative strokes than atenolol or metoprolol: a single-center cohort study of 44,092 consecutive patients. ( Ashes, C; Beattie, WS; Hare, GM; Judelman, S; Mazer, CD; Tait, G; Wijeysundera, DN, 2013) |
| "Treatment with bisoprolol resulted in a trend to lower ventricular response rate in AF cases." | 6.74 | Postoperative oral amiodarone versus oral bisoprolol as prophylaxis against atrial fibrillation after coronary artery bypass graft surgery: a prospective randomized trial. ( Ashoush, R; El Rassi, I; Haddad, F; Hayeck, G; Jebara, V; Madi-Jebara, S; Sleilaty, G; Yazigi, A, 2009) |
| " Thus, the effect of bisoprolol on clinical status and plasma cytokine concentrations in ACHD patients with right heart failure after surgical correction for Tetralogy of Fallot was investigated." | 5.13 | Beta-blockade does not alter plasma cytokine concentrations and ventricular function in young adults with right ventricular dysfunction secondary to operated congenital heart disease. ( Bahlmann, J; Beibei, L; Buchhorn, R; Geyer, S; Kuehne, T; Loppnow, H; Norozi, K; Raab, B; Werdan, K; Wessel, A, 2008) |
| "The authors performed a double-blinded, placebo-controlled, multicenter trial to compare the effect of bisoprolol with that of placebo on 1-yr composite outcome including cardiovascular mortality, nonfatal myocardial infarction, unstable angina, congestive heart failure, and cerebrovascular insult." | 5.12 | Adrenergic receptor genotype but not perioperative bisoprolol therapy may determine cardiovascular outcome in at-risk patients undergoing surgery with spinal block: the Swiss Beta Blocker in Spinal Anesthesia (BBSA) study: a double-blinded, placebo-contro ( Bestmann, L; Blumenthal, S; Boltres, A; Borgeat, A; Furrer, L; Hersberger, M; Hofer, C; Kälin, G; Lucchinetti, E; Müller, A; Schulz, C; Spahn, DR; Wacker, J; Zaugg, M; Zollinger, A, 2007) |
| "Amlodipine is an effective treatment for hypertension." | 5.11 | Hemodynamic effects of amlodipine, bisoprolol, and lisinopril in hypertensive patients after liver transplantation. ( Alexander, GJ; Brown, MJ; Byrne, CD; Neal, DA; Wilkinson, IB, 2004) |
| "Bisoprolol reduces the perioperative incidence of death from cardiac causes and nonfatal myocardial infarction in high-risk patients who are undergoing major vascular surgery." | 5.09 | The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group. ( Baars, HF; Bax, JJ; Blankensteijn, JD; Boersma, E; Poldermans, D; Roelandt, JR; Thomson, IR; Trocino, G; van de Ven, LL; van Urk, H; Vigna, C; Yo, TI, 1999) |
| "Bisoprolol significantly reduced long-term cardiac death and myocardial infarction in high-risk patients after successful major cardiac vascular surgery." | 5.09 | Bisoprolol reduces cardiac death and myocardial infarction in high-risk patients as long as 2 years after successful major vascular surgery. ( Baars, HF; Bax, JJ; Boersma, E; Paelinck, B; Poldermans, D; Roelandt, JR; Scheffer, MG; Thomson, IR; Trocino, G; van de Ven, LL; van Urk, H; Vigna, C, 2001) |
| "Bisoprolol was associated with a significant reduction of 30-day cardiac death and nonfatal MI, while fluvastatin showed a trend for improved outcome." | 3.84 | Bisoprolol and fluvastatin for the reduction of perioperative cardiac mortality and myocardial infarction in intermediate-risk patients undergoing noncardiovascular surgery: a randomized controlled trial (DECREASE-IV). ( Bax, JJ; Boersma, E; Dunkelgrun, M; Koopman-van Gemert, AW; Poldermans, D; Schouten, O; Thomson, IR; van Poorten, F, 2009) |
| "The use of metoprolol and atenolol is associated with increased risks of postoperative stroke, compared with bisoprolol." | 3.79 | Selective β1-antagonism with bisoprolol is associated with fewer postoperative strokes than atenolol or metoprolol: a single-center cohort study of 44,092 consecutive patients. ( Ashes, C; Beattie, WS; Hare, GM; Judelman, S; Mazer, CD; Tait, G; Wijeysundera, DN, 2013) |
| "Treatment with bisoprolol resulted in a trend to lower ventricular response rate in AF cases." | 2.74 | Postoperative oral amiodarone versus oral bisoprolol as prophylaxis against atrial fibrillation after coronary artery bypass graft surgery: a prospective randomized trial. ( Ashoush, R; El Rassi, I; Haddad, F; Hayeck, G; Jebara, V; Madi-Jebara, S; Sleilaty, G; Yazigi, A, 2009) |
| "Fifteen patients experienced persistent atrial fibrillation and were treated with electrical cardioversion during hospitalization." | 1.91 | Managing postoperative atrial fibrillation after open-heart surgery using transdermal β ( Enomoto, S; Hamuro, M; Kurokawa, S; Miwa, S; Setozaki, S; Yamada, T; Yamamoto, K, 2023) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (10.00) | 18.2507 |
| 2000's | 13 (43.33) | 29.6817 |
| 2010's | 11 (36.67) | 24.3611 |
| 2020's | 3 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wongcharoen, W | 1 |
| Chotayaporn, T | 1 |
| Chutikhongchalermroj, K | 1 |
| Tantraworasin, A | 1 |
| Saeteng, S | 1 |
| Arworn, S | 1 |
| Rerkasem, K | 1 |
| Phrommintikul, A | 1 |
| Yamamoto, K | 1 |
| Miwa, S | 1 |
| Yamada, T | 1 |
| Setozaki, S | 1 |
| Hamuro, M | 1 |
| Kurokawa, S | 1 |
| Enomoto, S | 1 |
| Iwano, T | 1 |
| Toda, H | 1 |
| Nakamura, K | 1 |
| Shimizu, K | 1 |
| Ejiri, K | 1 |
| Naito, Y | 1 |
| Mori, H | 1 |
| Masuda, T | 1 |
| Miyoshi, T | 1 |
| Yoshida, M | 1 |
| Hikasa, Y | 1 |
| Morimatsu, H | 1 |
| Ito, H | 1 |
| Ashes, C | 2 |
| Judelman, S | 2 |
| Wijeysundera, DN | 1 |
| Tait, G | 2 |
| Mazer, CD | 2 |
| Hare, GM | 2 |
| Beattie, WS | 2 |
| Eisenach, JC | 1 |
| Surkova, EA | 1 |
| Dupliakov, DV | 1 |
| Furuichi, Y | 1 |
| Sakamoto, A | 1 |
| Wicker, JF | 1 |
| Bronheim, D | 1 |
| Wijeysundera, D | 1 |
| Kmietowicz, Z | 1 |
| Garganeeva, AA | 1 |
| Shabanova, MV | 1 |
| Jackson, MW | 1 |
| Taylor, RJ | 1 |
| Sleilaty, G | 1 |
| Madi-Jebara, S | 1 |
| Yazigi, A | 1 |
| Haddad, F | 1 |
| Hayeck, G | 1 |
| El Rassi, I | 1 |
| Ashoush, R | 1 |
| Jebara, V | 1 |
| Dunkelgrun, M | 1 |
| Boersma, E | 4 |
| Schouten, O | 2 |
| Koopman-van Gemert, AW | 1 |
| van Poorten, F | 1 |
| Bax, JJ | 4 |
| Thomson, IR | 3 |
| Poldermans, D | 5 |
| Weiskopf, RB | 1 |
| Mahmoud, KM | 1 |
| Ammar, AS | 1 |
| Fleisher, LA | 1 |
| Corbett, W | 1 |
| Berry, C | 1 |
| Neal, DA | 1 |
| Brown, MJ | 1 |
| Wilkinson, IB | 1 |
| Byrne, CD | 1 |
| Alexander, GJ | 1 |
| Visser, L | 1 |
| Kertai, MD | 1 |
| Klein, J | 1 |
| van Urk, H | 3 |
| Simoons, ML | 1 |
| van de Ven, LL | 3 |
| Vermeulen, M | 1 |
| Lameris, TW | 1 |
| Zaugg, M | 1 |
| Bestmann, L | 1 |
| Wacker, J | 1 |
| Lucchinetti, E | 1 |
| Boltres, A | 1 |
| Schulz, C | 1 |
| Hersberger, M | 1 |
| Kälin, G | 1 |
| Furrer, L | 1 |
| Hofer, C | 1 |
| Blumenthal, S | 1 |
| Müller, A | 1 |
| Zollinger, A | 1 |
| Spahn, DR | 1 |
| Borgeat, A | 1 |
| Norozi, K | 1 |
| Buchhorn, R | 1 |
| Wessel, A | 1 |
| Bahlmann, J | 1 |
| Raab, B | 1 |
| Geyer, S | 1 |
| Kuehne, T | 1 |
| Beibei, L | 1 |
| Werdan, K | 1 |
| Loppnow, H | 1 |
| Günnicker, M | 1 |
| Freund, U | 1 |
| Grebe, EJ | 1 |
| Scherer, R | 1 |
| Schieffer, M | 1 |
| Zerkowski, HR | 1 |
| Hess, W | 1 |
| Blankensteijn, JD | 1 |
| Baars, HF | 2 |
| Yo, TI | 1 |
| Trocino, G | 2 |
| Vigna, C | 2 |
| Roelandt, JR | 2 |
| Lee, TH | 1 |
| Dickerson, LM | 1 |
| Carek, PJ | 1 |
| Feldman, T | 1 |
| Fusman, B | 1 |
| McKinsey, JF | 1 |
| Möllhoff, T | 1 |
| Buerkle, H | 1 |
| Van Aken, H | 1 |
| Brodner, G | 1 |
| Prichard, BN | 1 |
| Robin, JM | 1 |
| Paelinck, B | 1 |
| Scheffer, MG | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Multicenter Randomized Controlled Trial of Loading Dose Statins for the Prevention of Cardiovascular Complications in High-Risk Non-Cardiac Surgery[NCT01543555] | Phase 3 | 648 participants (Actual) | Interventional | 2012-11-30 | Completed | ||
| Pilot Study to Assess Blockade of Calcium Channels and Sodium Chloride Cotransporters for Physiologic Abnormalities in Liver Transplant Associated Hypertension[NCT05275907] | Phase 4 | 0 participants (Actual) | Interventional | 2022-07-12 | Withdrawn (stopped due to Screened participants did not meet inclusion criteria prior to study completion date) | ||
| Using Heart Rate Variability to Analyze the Effect of Beta Blockers on Intermediate Risk Patients Undergoing Laparoscopic Surgical Procedures[NCT01330654] | 0 participants (Actual) | Interventional | 2011-03-31 | Withdrawn (stopped due to no patients were enrolled. Study was closed prior to study start.) | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
4 reviews available for bisoprolol and Postoperative Complications
| Article | Year |
|---|---|
[Effect of therapy with bisoprolol in postoperative period on rate of cardiac complications of extracardiac surgical interventions].
Topics: Adrenergic beta-1 Receptor Antagonists; Bisoprolol; Humans; Meta-Analysis as Topic; Myocardial Infar | 2013 |
[Perioperative cardiovascular evaluation and management for noncardiac surgery].
Topics: Adrenergic beta-Antagonists; Anesthesia; Atenolol; Bisoprolol; Fatty Acids, Monounsaturated; Fluvast | 2014 |
Bisoprolol and fluvastatin for the reduction of perioperative cardiac mortality and myocardial infarction in intermediate-risk patients undergoing noncardiovascular surgery: a randomized controlled trial (DECREASE-IV).
Topics: Adrenergic beta-Antagonists; Aged; Bisoprolol; Cohort Studies; Drug Therapy, Combination; Fatty Acid | 2009 |
[Efficacy of oncologic surgery. Does anesthesia influence the postoperative outcome?].
Topics: Adrenergic alpha-Agonists; Adrenergic beta-Antagonists; Aged; Anesthesia; Atenolol; Bisoprolol; Clin | 2001 |
10 trials available for bisoprolol and Postoperative Complications
17 other studies available for bisoprolol and Postoperative Complications
| Article | Year |
|---|---|
Managing postoperative atrial fibrillation after open-heart surgery using transdermal β
Topics: Atrial Fibrillation; Bisoprolol; Cardiac Surgical Procedures; Electric Countershock; Heart Rate; Hum | 2023 |
Selective β1-antagonism with bisoprolol is associated with fewer postoperative strokes than atenolol or metoprolol: a single-center cohort study of 44,092 consecutive patients.
Topics: Adrenergic beta-1 Receptor Antagonists; Aged; Atenolol; Bisoprolol; Cohort Studies; Female; Humans; | 2013 |
Patient safety: anesthesiology contributions and supplements to the American Society of Anesthesiologists' Annual Meeting.
Topics: Adrenergic beta-1 Receptor Antagonists; Atenolol; Bisoprolol; Female; Humans; Male; Metoprolol; Post | 2013 |
Does β selectivity really affect outcome?
Topics: Adrenergic beta-1 Receptor Antagonists; Atenolol; Bisoprolol; Female; Humans; Male; Metoprolol; Post | 2014 |
In reply.
Topics: Adrenergic beta-1 Receptor Antagonists; Atenolol; Bisoprolol; Female; Humans; Male; Metoprolol; Post | 2014 |
Researchers "disappointed" that influential study was not retracted.
Topics: Adrenergic beta-1 Receptor Antagonists; Bisoprolol; Humans; Myocardial Infarction; Postoperative Com | 2014 |
[Effect of optimal pulse slowing therapy on the course of recovery period in patients with ischemic heart disease after surgical myocardial revascularization].
Topics: Benzazepines; Bisoprolol; Cardiovascular Agents; Comparative Effectiveness Research; Drug Monitoring | 2014 |
New-Onset Heart Failure in a Patient With a Pacemaker: An Unusual Cause.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Aortic Valve Stenosis; Atrial Fibrillation; Bisoprolol; Ca | 2016 |
Perioperative use of beta-adrenergic antagonists and anemia: known knowns, known unknowns, unknown unknowns; and Unknown Knowns.
Topics: Adrenergic beta-Antagonists; Anemia; Bisoprolol; Heart Rate; Hospital Mortality; Humans; Postoperati | 2010 |
Cost-effectiveness of differing perioperative beta-blockade strategies in vascular surgery patients.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Aortic Aneurysm, Abdominal; Atenolol; Bisoprolol; | 2004 |
Fluvastatin and bisoprolol for the reduction of perioperative cardiac mortality and morbidity in high-risk patients undergoing non-cardiac surgery: rationale and design of the DECREASE-IV study.
Topics: Adrenergic beta-Antagonists; Adult; Bisoprolol; Cardiovascular Diseases; Drug Therapy, Combination; | 2004 |
[Effect of dopexamine on the hemodynamics of coronary surgery patients with and without bisoprolol blockade].
Topics: Adrenergic beta-Agonists; Adult; Aged; Bisoprolol; Cardiac Output, Low; Coronary Artery Bypass; Coro | 1993 |
Reducing cardiac risk in noncardiac surgery.
Topics: Adrenergic beta-Antagonists; Bisoprolol; Heart Diseases; Humans; Incidence; Myocardial Infarction; M | 1999 |
Bisoprolol prevents mortality and myocardial infarction after vascular surgery.
Topics: Adrenergic beta-Antagonists; Aged; Bisoprolol; Female; Heart Diseases; Humans; Male; Multicenter Stu | 2000 |
Beta-blockade for patients undergoing vascular surgery.
Topics: Adrenergic beta-Antagonists; Bisoprolol; Humans; Myocardial Infarction; Postoperative Complications; | 2000 |
Beta-blockade and surgery.
Topics: Adrenergic beta-Antagonists; Bisoprolol; Heart Diseases; Humans; Myocardial Infarction; Myocardial I | 2001 |
[Vascular interventions. Beta blocker protects the heart].
Topics: Adrenergic beta-Antagonists; Arterial Occlusive Diseases; Bisoprolol; Clinical Trials as Topic; Huma | 2001 |